Health
Soluble ACE2 microbody blocks SARS-CoV-2 entry into lung cells – News-Medical.Net
A new study by researchers at NYU Langone Medical Center and Weill Cornell Medical College and published on the preprint server bioRxiv* in September 2020 reports the potential of an angiotensin-converting enzyme 2 (ACE2)-antibody Fc complex in a new format t…
As the COVID-19 pandemic continues to spread in many parts of the world, there is an urgent need for a preventative vaccine and improved therapeutics. A new study by researchers at NYU Langone Medical Center and Weill Cornell Medical College and published on the preprint server bioRxiv* in September 2020 reports the potential of an angiotensin-converting enzyme 2 (ACE2)-antibody Fc complex in a new format that seems to offer more significant inhibition of SARS-CoV-2.
ACE2 has been one of the pr…
